D Walmrath, T Schneider, R Schermuly, H Olschewski, F Grimminger and W Seeger
Department of Internal Medicine, Justus-Liebig University, Giessen, Germany.

Inhalation of NO and aerosolization of PGI2 have been suggested to achieve selective pulmonary vasodilation and improvement of arterial oxygenation in patients with ARDS. We directly compared these two modes of transbronchial vasodilator therapy in 16 ARDS patients mechanically ventilated (mean lung injury score [1] 2.75 +/- 0.05). Patients were randomized to receive either first NO and then PGI2, or vice versa. Each drug was individually titrated to find the maximum improvement of arterial oxygenation. Gas exchange variables, including data from the multiple inert gas elimination technique (MIGET), and hemodynamics under application of NO/PGI2 were compared with pre- and post-challenge values. NO (17.8 +/- 2.7 ppm) increased Pa O2/FI O2 from 115 +/- 12 to 144 +/- 15 mm Hg (p<0.01) and reduced the shunt-flow from 33.1 +/- 3.6 to 26.6 +/- 4.5% (p<0.05). Aerosolized PGI2 (7.5 +/- 2.5 ng/kg min) augmented Pa O2/FI O2 from 114 +/- 12 to 135 +/- 12 mm Hg (p<0.01), and decreased shunt from 33.5 +/- 3.8 to 26.0 +/- 3.9% (p<0.05). In 10 patients, both NO and PGI2 caused an increase in Pa O2/FI O2 by at least 10 mm Hg. Two further patients displayed an improvement of arterial oxygenation in response to either NO or PGI2. NO decreased mean pulmonary artery pressure from 34.8 +/- 2.2 to 33.0 +/- 1.8 mm Hg, and PGI2 from 35.0 +/- 2.2 to 31.9 +/- 1.7 mm Hg (p<0.05). We conclude that individually titrated doses of inhaled NO and aerosolized PGI2 effect selective pulmonary vasodilation and redistribute blood-flow from shunt-areas to well-ventilated regions with nearly identical efficacy profiles.

This article has been cited by other articles:

				M. Gomberg-Maitland and H. Olschewski Prostacyclin therapies for the treatment of pulmonary arterial hypertension Eur. Respir. J., April 1, 2008; 31(4): 891 - 901. [Abstract] [Full Text] [PDF]

				M. Cepkova and M. A. Matthay Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med, May 1, 2006; 21(3): 119 - 143. [Abstract] [PDF]

				M. J.D. Griffiths and T. W. Evans Inhaled Nitric Oxide Therapy in Adults N. Engl. J. Med., December 22, 2005; 353(25): 2683 - 2695. [Full Text] [PDF]

				B. L. Sandifer, K. L. Brigham, E. C. Lawrence, D. Mottola, C. Cuppels, and R. E. Parker Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation J Appl Physiol, December 1, 2005; 99(6): 2363 - 2368. [Abstract] [Full Text] [PDF]

				B. S. Burleson and E. D. Maki Acute Respiratory Distress Syndrome Journal of Pharmacy Practice, April 1, 2005; 18(2): 118 - 131. [Abstract] [PDF]

				B. M. Tsai, M. Wang, M. W. Turrentine, Y. Mahomed, J. W. Brown, and D. R. Meldrum Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies Ann. Thorac. Surg., July 1, 2004; 78(1): 360 - 368. [Abstract] [Full Text] [PDF]

				N. Adhikari and J. T. Granton Inhaled Nitric Oxide for Acute Lung Injury: No Place for NO? JAMA, April 7, 2004; 291(13): 1629 - 1631. [Full Text] [PDF]

				C. J. De Wet, D. G. Affleck, E. Jacobsohn, M. S. Avidan, H. Tymkew, L. L. Hill, P. B. Zanaboni, N. Moazami, and J. R. Smith Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1058 - 1067. [Abstract] [Full Text] [PDF]

				C. Gessner, S. Hammerschmidt, H. Kuhn, T. Lange, L. Engelmann, J. Schauer, and H. Wirtz Exhaled Breath Condensate Nitrite and Its Relation to Tidal Volume in Acute Lung Injury Chest, September 1, 2003; 124(3): 1046 - 1052. [Abstract] [Full Text] [PDF]

				E.D. Moloney and T.W. Evans Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome Eur. Respir. J., April 1, 2003; 21(4): 720 - 727. [Abstract] [Full Text] [PDF]

				A. Sablotzki, E. Czeslick, S. Schubert, I. Friedrich, J. Muhling, M. G. Dehne, S. Grond, and T. Hentschel Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension: [L'iloprost ameliore l'hemodynamique chez des malades souffrant d'insuffisance cardiaque chronique et d'hypertension arterielle pulmonaire] Can J Anesth, December 1, 2002; 49(10): 1076 - 1080. [Abstract] [Full Text] [PDF]

				A. Sablotzki, T. Hentschel, E. Gruenig, S. Schubert, I. Friedrich, J. Muhling, M. G. Dehne, and E. Czeslick Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 746 - 752. [Abstract] [Full Text] [PDF]

				J Cranshaw, M J D Griffiths, and T W Evans The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS Thorax, September 1, 2002; 57(9): 823 - 829. [Abstract] [Full Text] [PDF]

				H. Olschewski, G. Simonneau, N. Galie, T. Higenbottam, R. Naeije, L. J. Rubin, S. Nikkho, R. Speich, M. M. Hoeper, J. Behr, et al. Inhaled Iloprost for Severe Pulmonary Hypertension N. Engl. J. Med., August 1, 2002; 347(5): 322 - 329. [Abstract] [Full Text] [PDF]

				R. T. Schermuly, A. Roehl, N. Weissmann, H. A. Ghofrani, H. Leuchte, F. Grimminger, W. Seeger, and D. Walmrath Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1361 - L1368. [Abstract] [Full Text] [PDF]

				A. Haraldsson, N. Kieler-Jensen, and S.-E. Ricksten The Additive Pulmonary Vasodilatory Effects of Inhaled Prostacyclin and Inhaled Milrinone in Postcardiac Surgical Patients with Pulmonary Hypertension Anesth. Analg., December 1, 2001; 93(6): 1439 - 1445. [Abstract] [Full Text] [PDF]

				S. M. Fiser, J. T. Cope, I. L. Kron, A. K. Kaza, S. M. Long, J. A. Kern, and C. G. Tribble Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 981 - 982. [Full Text] [PDF]

				M. Baldauf, P. Silver, and M. Sagy Evaluating the Validity of Responsiveness to Inhaled Nitric Oxide in Pediatric Patients With ARDS : An Analytic Tool Chest, April 1, 2001; 119(4): 1166 - 1172. [Abstract] [Full Text] [PDF]

				J. B. Zwischenberger, S. K. Alpard, and A. Bidani Severe respiratory failure Ann. Thorac. Surg., January 1, 2001; 71(1): 394 - 396. [Full Text] [PDF]

				P. Schenk, V. Petkov, C. Madl, L. Kramer, M. Kneussl, R. Ziesche, and I. Lang Aerosolized Iloprost Therapy Could Not Replace Long-term IV Epoprostenol (Prostacyclin) Administration in Severe Pulmonary Hypertension Chest, January 1, 2001; 119(1): 296 - 300. [Abstract] [Full Text] [PDF]

				R. A. Schroeder, G. L. Wood, J. S. Plotkin, and P. C. Kuo Intraoperative Use of Inhaled PGI2 for Acute Pulmonary Hypertension and Right Ventricular Failure Anesth. Analg., August 1, 2000; 91(2): 291 - 295. [Abstract] [Full Text] [PDF]

				H. Olschewski, H. A. Ghofrani, T. Schmehl, J. Winkler, H. Wilkens, M. M. Hoper, J. Behr, F.-X. Kleber, W. Seeger, and for the German PPH Study Group* Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial Ann Intern Med, March 21, 2000; 132(6): 435 - 443. [Abstract] [Full Text] [PDF]

				R. T. Schermuly, A. Roehl, N. Weissmann, H. A. Ghofrani, C. Schudt, H. Tenor, F. Grimminger, W. Seeger, and D. Walmrath Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 512 - 520. [Abstract] [Full Text]

				R. T. SCHERMULY, A. GÜNTHER, N. WEISSMANN, H. A. GHOFRANI, W. SEEGER, F. GRIMMINGER, and D. WALMRATH Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (VA/Q) Mismatch in a Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 152 - 159. [Abstract] [Full Text]

				R. T. SCHERMULY, H. A. GHOFRANI, B. ENKE, N. WEISSMANN, F. GRIMMINGER, W. SEEGER, C. SCHUDT, and D. WALMRATH Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1500 - 1506. [Abstract] [Full Text]

				F. ROSE, K. ZWICK, H. A. GHOFRANI, U. SIBELIUS, W. SEEGER, D. WALMRATH, and F. GRIMMINGER Prostacyclin Enhances Stretch-induced Surfactant Secretion in Alveolar Epithelial Type II Cells Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 846 - 851. [Abstract] [Full Text]

				H. OLSCHEWSKI, H. ARDESCHIR GHOFRANI, D. WALMRATH, R. SCHERMULY, B. TEMMESFELD-WOLLBRÜCK, F. GRIMMINGER, and W. SEEGER Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 600 - 607. [Abstract] [Full Text]

				L. L. Hill and R. G. Pearl Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension J Appl Physiol, April 1, 1999; 86(4): 1160 - 1164. [Abstract] [Full Text] [PDF]

				S. BHORADE, J. CHRISTENSON, M. O'CONNOR, A. LAVOIE, A. POHLMAN, and J. B. HALL Response to Inhaled Nitric Oxide in Patients with Acute Right Heart Syndrome Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 571 - 579. [Abstract] [Full Text]

				A. P. Wheeler and G. R. Bernard Treating Patients with Severe Sepsis N. Engl. J. Med., January 21, 1999; 340(3): 207 - 214. [Full Text] [PDF]

				H. Heller, G. Hoffmann, K.-D. Schuster, W. Schobersberger;, W. Steudel, and W. Seeger Letters to the Editor J Appl Physiol, June 1, 1998; 84(6): 2200 - 2201. [Abstract] [Full Text] [PDF]

				C. PUTENSEN, C. HORMANN, A. KLEINSASSER, and G. PUTENSEN-HIMMER Cardiopulmonary Effects of Aerosolized Prostaglandin E1 and Nitric Oxide Inhalation in Patients with Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1743 - 1747. [Abstract] [Full Text] [PDF]

				S. C. Body and S. K. Shernan The Utility of Nitric Oxide in the Postoperative Period Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 4 - 30. [Abstract] [PDF]

				H. Schütte, F. Grimminger, J. Otterbein, R. Spriestersbach, K. Mayer, D. Walmrath, and W. Seeger Efficiency of Aerosolized Nitric Oxide Donor Drugs to Achieve Sustained Pulmonary Vasodilation J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 985 - 994. [Abstract] [Full Text]

				R. SCHERMULY, T. SCHMEHL, A. GÜNTHER, F. GRIMMINGER, W. SEEGER, and D. WALMRATH Ultrasonic Nebulization for Efficient Delivery of Surfactant in a Model of Acute Lung Injury . Impact on Gas Exchange Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 445 - 453. [Abstract] [Full Text]

				J. R. MICHAEL, R. G. BARTON, J. R. SAFFLE, M. MONE, B. A. MARKEWITZ, K. HILLIER, M. R. ELSTAD, E. J. CAMPBELL, B. E. TROYER, R. E. WHATLEY, et al. Inhaled Nitric Oxide Versus Conventional Therapy . Effect on Oxygenation in ARDS Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1372 - 1380. [Abstract] [Full Text]

				E. TRONCY, J.-P. COLLET, S. SHAPIRO, J.-G. GUIMOND, L. BLAIR, T. DUCRUET, M. CHARBONNEAU, and G. BLAISE Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome . A Pilot Randomized Controlled Study Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1483 - 1488. [Abstract] [Full Text]